Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $114.49 | $24.66 | 364.31% | 216.02x | 196.25x | 14.52x | 17.54x | 1.67x | $106.92M | 0.89% | $705.78M | 6.70 | $12.27B | 1,564.64 | ||
| LQDA | LIQUIDIA CORP | $84.11 | $17.14 | 390.66% | 350.46x | 25.31x | 25.70x | 68.89x | 1.70x | $41.15M | 0.56% | $108.58M | 1.23 | $7.44B | 138.85 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.08 | $2.70 | 199.44% | 115.43x | 72.01x | 4.38x | 107.21x | 1.11x | $47.52M | 3.45% | $13.01M | 0.08 | $1.54B | 28.85 | ||
| HALO | HALOZYME THERAPEUTICS INC | $82.54 | $68.06 | 21.27% | 27.89x | 9.94x | 6.46x | 44.58x | 0.50x | $667.65M | 6.85% | $219.64M | 1.86 | $11.62B | 18.63 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $205.52 | $95.06 | 116.19% | 33.69x | 28.37x | 5.72x | 20.31x | 1.03x | $793.95M | 2.89% | $1.35B | 10.14 | $28.78B | 24.40 | ||
| ADMA | ADMA BIOLOGICS INC | $8.46 | $8.80 | -3.85% | 12.26x | 10.08x | 3.92x | 5.02x | 0.51x | $107.90M | 5.40% | $390.33M | 1.65 | $2.02B | 9.12 | ||
| ASND | ASCENDIS PHARMA A | $243.91 | $76.61 | 218.38% | 25.85x | 16.77x | 14.87x | 26.39x | 2.70x | $52.94M | 0.35% | $574.09M | 9.24 | $15.53B | 166.54 | ||
| KRYS | KRYSTAL BIOTECH INC | $341.12 | $87.69 | 289.00% | 44.02x | 44.73x | 23.94x | 7.88x | 2.25x | $237.38M | 2.38% | $1.28B | 43.59 | $9.56B | 44.70 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $74.34 | $16.50 | 350.48% | 69.48x | 59.05x | 6.86x | 8.87x | 2.15x | $182.84M | 3.17% | $654.15M | 8.43 | $5.63B | 46.96 | ||
| RPRX | ROYALTY PHARMA PLC | $58.43 | $38.84 | 50.46% | 30.59x | 10.89x | 10.46x | 3.39x | 0.64x | $2.34B | 9.17% | $9.94B | 22.75 | $42.02B | 36.11 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.02 | $37.52 | 59.95% | 42.87x | 16.16x | 3.56x | 1.87x | 0.63x | $767.06M | 6.64% | $6.21B | 32.27 | $9.96B | 20.64 | ||
| VCEL | VERICEL CORP | $45.96 | $8.93 | 414.52% | 95.75x | 95.33x | 7.66x | 6.36x | 2.27x | $61.66M | 2.63% | $370.04M | 7.25 | $2.32B | 52.69 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $287.54 | $97.85 | 193.85% | 36.40x | 31.12x | 20.83x | 5.78x | 1.59x | $122.22M | 2.14% | $997.32M | 50.16 | $6.10B | 27.04 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $252.86 | $47.12 | 436.62% | 538.00x | 9.79x | 3.53x | 3.50x | 1.82x | $1.30B | 8.29% | $4.53B | 73.22 | $19.42B | 28.77 | ||
| TGTX | TG THERAPEUTICS INC | $52.03 | $23.40 | 122.31% | 16.16x | 36.92x | 10.73x | 13.66x | 2.33x | -$14.19M | -0.19% | $583.13M | 4.04 | $8.27B | 55.15 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.24 | $33.63 | 4.79% | 13.93x | 9.28x | 2.27x | 2.24x | 0.54x | $341.79M | 16.77% | $910.35M | 15.75 | $1.61B | 6.79 | ||
| TECH | BIO-TECHNE CORP | $72.09 | $16.02 | 350.12% | 101.54x | 34.55x | 9.31x | 5.41x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.37B | 44.41 | ||
| MDXG | MIMEDX GROUP INC | $4.13 | $1.11 | 271.39% | 103.25x | -36.81x | 1.72x | 2.79x | 1.46x | $44.50M | 7.29% | $216.00M | 1.46 | $483.36M | 21.19 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.17 | $8.59 | -86.37% | 4.33x | -3.96x | 1.10x | 1.28x | 0.05x | $7.24M | 10.77% | $52.93M | 0.92 | $14.09M | 0.91 | ||
| UTHR | UNITED THERAPEUTICS CORP | $517.71 | $228.25 | 126.82% | 17.68x | 18.92x | 7.10x | 3.72x | 2.06x | $1.02B | 4.52% | $5.90B | 135.66 | $20.70B | 12.08 | ||
| EXEL | EXELIXIS INC | $53.03 | $29.06 | 82.50% | 17.00x | 16.48x | 5.77x | 6.89x | 1.28x | $917.69M | 6.70% | $1.94B | 7.49 | $13.27B | 12.57 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.40 | $1.96 | 73.18% | 14.17x | 14.71x | 2.08x | 3.29x | 1.45x | $4.11M | 1.50% | $82.33M | 1.03 | $206.82M | 9.74 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $477.10 | $158.66 | 200.71% | 28.05x | 24.67x | 9.92x | 6.25x | 2.10x | $3.71B | 3.06% | $19.36B | 76.20 | $117.58B | 21.80 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $762.63 | $416.55 | 83.08% | 18.18x | 16.33x | 5.05x | 2.48x | 1.19x | $3.76B | 4.80% | $31.71B | 308.48 | $78.77B | 13.70 | ||
| INCY | INCYTE CORP | $119.52 | $60.41 | 97.84% | 14.72x | 15.72x | 4.12x | 3.82x | 1.97x | $1.92B | 8.02% | $6.34B | 31.66 | $20.27B | 9.80 | ||
| VCYT | VERACYTE INC | $46.32 | $8.62 | 437.29% | 41.73x | 41.77x | 6.80x | 2.75x | 4.91x | $155.34M | 4.22% | $1.34B | 16.90 | $3.47B | 30.17 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.